What is Microbiosensor?
Microbiosensor Ltd. is at the forefront of developing advanced point-of-care diagnostic devices. Leveraging proprietary chemical reagents, their MicroBioSensors offer a rapid, color-change-based detection system for bacterial infections. This technology serves as an early warning system, enabling healthcare professionals to swiftly assess leukocyte levels and antibiotic sensitivities. Designed to augment existing laboratory workflows, Microbiosensor's innovations aim to enhance patient care outcomes and combat the growing threat of antimicrobial resistance. Their solutions are particularly valuable for peritoneal dialysis professionals and other medical practitioners requiring swift and dependable diagnostic insights.
How much funding has Microbiosensor raised?
Microbiosensor has raised a total of $920K across 1 funding round:
Private Equity
$920K
Private Equity (2017): $920K with participation from Northern Powerhouse Investment Fund
Key Investors in Microbiosensor
Northern Powerhouse Investment Fund
The Northern Powerhouse Investment Fund is dedicated to investing in skills, innovation, transport, and culture to boost the local economy in Northern England.
What's next for Microbiosensor?
The substantial enterprise-level funding secured by Microbiosensor signals a strategic pivot towards scaling its operations and broadening its market reach. This capital infusion is expected to accelerate product development, enhance manufacturing capabilities, and support expanded commercialization efforts. With a focus on addressing critical needs in infection detection and antimicrobial resistance, Microbiosensor is poised to solidify its position as a key player in the diagnostics industry. Future growth will likely involve strategic partnerships and further technological advancements to maintain its competitive edge.
See full Microbiosensor company page
